American commitments in international treaties do not forbid the U.S. Drug Enforcement Administration from rescheduling marijuana as recommended, a California congresswoman told the agency.
The DEA has yet to respond to an Aug. 29 recommendation from the Department of Health and Human Services (HHS) to move cannabis from Schedule 1 to Schedule 3 of the Controlled Substances Act, part of a rescheduling review ordered in October 2022 by President Joe Biden.
ADVERTISEMENT
Some experts have questioned whether U.S. obligations under compacts such as the United Nations’ Single Convention on Narcotic Drugs of 1961 might prove to be a rescheduling roadblock.
But U.S. Rep. Sydney Kamlager-Dove, a California Democrat, told the DEA that U.S. treaties should have no impact on rescheduling.
“Applicable Treaties neither require
Read full article on Marijuana Business Daily
